CNBX Pharmaceuticals Inc. (CNBX) Gross Profit (2016 - 2024)
CNBX Pharmaceuticals' (CNBX) quarterly Gross Profit came in at $34417.0 in Q1 2024, up 941.36% on a QoQ basis from $3305.0 in Q4 2018.
CNBX Pharmaceuticals Inc. (CNBX) Gross Profit (2016 - 2024) Analysis & Trends
CNBX Pharmaceuticals (CNBX) has 4 years of Gross Profit data on file, last reported at $34417.0 in Q1 2024.
- Quarterly Gross Profit changed N/A year-over-year to $34417.0 in Q1 2024, while the trailing twelve-month figure through Feb 2026 was $34417.0 (down 8.76% YoY) and the FY2024 annual result came in at $130074.0, down 68.19% from the prior year.
- Gross Profit climbed to $34417.0 in Q1 2024, from $3305.0 in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $34417.0 in Q1 2024 to a low of $34417.0 in Q1 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 29, 2024 | 34,417.00 |
| Feb 29, 2024 | 34,417.00 |
| Nov 30, 2018 | 3,305.00 |
| Nov 30, 2018 | 3,305.00 |
| Feb 28, 2018 | 1,931.00 |
| Feb 28, 2018 | 1,931.00 |
| Nov 30, 2017 | 1,758.00 |
| Nov 30, 2017 | 1,758.00 |
| Aug 31, 2017 | 2,870.00 |
| Aug 31, 2017 | 2,870.00 |
| May 31, 2017 | 1,571.00 |
| May 31, 2017 | 1,571.00 |
| Feb 28, 2017 | 1,243.00 |
| Feb 28, 2017 | 1,243.00 |
| Aug 31, 2016 | 50,000.00 |
| Aug 31, 2016 | 50,000.00 |
| May 31, 2016 | 50,000.00 |
| May 31, 2016 | 50,000.00 |
| Feb 29, 2016 | 12,500.00 |
| Feb 29, 2016 | 12,500.00 |